Skip to content

Drug interactions

Bazedoxifene / conjugated estrogens + Fondaparinux

Severity: Major

Bazedoxifene / conjugated estrogens and Fondaparinux: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Estrogens and bazedoxifene both increase venous thromboembolism risk, which works against fondaparinux given to treat or prevent clots. The combination is generally inappropriate in patients with active thrombosis.

What this interaction means in plain words

Bazedoxifene / conjugated estrogens and Fondaparinux can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Pharmacodynamic opposition: estrogen-induced prothrombotic changes versus factor Xa inhibition.

What to do

Avoid the estrogen combination in active or recent VTE and consider non-hormonal therapy. Reassess VTE risk regularly if continued.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bazedoxifene / conjugated estrogens and Fondaparinux, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bazedoxifene / conjugated estrogens with Fondaparinux?

MediHelp rates the interaction as major. Bazedoxifene / conjugated estrogens and Fondaparinux can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Estrogens and bazedoxifene both increase venous thromboembolism risk, which works against fondaparinux given to treat or prevent clots. The combination is generally inappropriate in patients with active thrombosis.

How serious is the interaction between Bazedoxifene / conjugated estrogens and Fondaparinux?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the estrogen combination in active or recent VTE and consider non-hormonal therapy. Reassess VTE risk regularly if continued.

What other medicines interact with Fondaparinux?

MediHelp also lists interactions of Fondaparinux with, for example, Defibrotide, Ketorolac, Abciximab. The full list is on the Fondaparinux page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in